Application note: A Simoa ™ Pharmacokinetic Bridging Assay 1SHARES Share via Pinterest Reddit Buffer Xing WhatsApp Flipboard Posted: 19 November 2019 | Quanterix | No comments yet Pharmacokinetics (PK) refers to the movement of a drug through the body. The distribution, absorption, metabolism, and excretion of a drug are all important pharmacokinetic factors to be considered in the development of therapeutics. The ability to detect and quantify the concentration of a therapeutic molecule with high sensitivity may be necessary for effective pharmacokinetic studies, especially if the drug is administered at a low dose. Here we describe a proof of concept assay to demonstrate the Simoa platform as a tool for measuring concentration of the biotherapeutic IgG Adalimumab (Humira®). A sandwich ELISA was created using anti Adalimumab antibodies as capture and detection.To compare performance, equivalent assays were run with the Simoa platform and a standard plate based ELISA. To read this Application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy. First Name * Surname * Job Title * Organisation * Town/City * Country * Email * Telephone * * This content is provided to you for free thanks to the kind support of our sponsor: Quanterix I am happy for my details to be shared with the sponsor(s) of this content *—Please choose an option—YesNo Related content from this organisation Application note: A Simoa™ Bridging Assay for Anti Drug Antibody Detection Application note: A Simoa ™ Pharmacokinetic Bridging Assay Application note: Cell Lysate Sample Handling with Simoa Bead-Based Assays Application note: Analysis of Inflammatory Plasma Biomarkers in Cancer Patient Samples Quanterix Related topicsAssays, Therapeutics Related organisationsQuanterix
webinar Solving the AOC puzzle: Strategies for chemistry, manufacturing and regulatory success By Abzena
news Beckman Coulter Life Sciences and Rarity Bioscience partner to advance oncology research By Drug Target Review